共 26 条
[11]
Amyloid beta oligomers induce Ca- (2+) dysregulation and neuronal death through activation of ionotropic glutamate receptors. ALBERDI E,SANCHEZ-GOMEZ M V,CAVALIERE F,et al. Cell Calcium . 2010
[12]
Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. MAEZAWA I,ZIMIN PI,WULFF H,et al. Journal of Biological Chemistry . 2011
[13]
Dual Effect of Beta-Amyloid onα7 andα4β2 Nicotinic Receptors Controlling the Release of Glutamate,Aspartate and GABA in Rat Hippocampus. MURA E,ZAPPETTINIS,PREDA S,et al. PLoS One . 2012
[14]
Isoflurane and desflurane at clinically relevant concentrations induce amyloid beta-peptide oligomerization: an NMR study. MANDAL P K,FODALE V. Biochemical and Biophysical Research Communications . 2009
[15]
Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. LU Y,WU X,DONG Y L,et al. Anesthesiology . 2010
[16]
Disease-modifying treatments for Alzheimer’’s disease. GAIJMBERTI D,SCARPINI. Therapeutic Advances in Neurological Disorders . 2011
[17]
Ameliorative effectsof a non-competitive BACE1 inhibitor TAK-070 on Aβpeptide lev-els and impaired learning behavior in aged rats. Takahashi H,Fukumoto H,Maeda R,et al. Brain Research . 2010
[18]
Resvera- trol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. Huang TC,Lu KT,Wo YY,Wu YJ,Yang YL. PLoS One . 2011
[19]
A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer’’s disease. Fukumoto H,Takahashi H,Tarui N,Matsui J,Tomita T,Hirode M,Sagayama M,Maeda R,Kawamoto M,Hirai K et al. The Journal of Neuroscience . 2010
[20]
CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. Reed-Geaghan E G,Savage J C,Hise A G, et al. The Journal of Neuroscience . 2009